Literature DB >> 8725395

Opioid receptor types and subtypes: the delta receptor as a model.

P A Zaki1, E J Bilsky, T W Vanderah, J Lai, C J Evans, F Porreca.   

Abstract

Since the discovery of opioid receptors over two decades ago, an increasing body of work has emerged supporting the concept of multiple opioid receptors. Molecular cloning has identified three opioid receptor types--mu, delta, and kappa--confirming pharmacological studies that previously postulated the existence of these three receptors. The cloned opioid receptors are highly homologous and belong to the family of seven-transmembrane, G protein-coupled receptors. With the development of novel opioid ligands, subtypes of the mu, delta, and kappa receptors have been proposed, although the molecular basis of these subtypes has not been elucidated. In this review, we present the pharmacological data supporting the concept of multiple delta opioid receptor subtypes and offer hypothetical mechanisms which might generate these "subtypes."

Mesh:

Substances:

Year:  1996        PMID: 8725395     DOI: 10.1146/annurev.pa.36.040196.002115

Source DB:  PubMed          Journal:  Annu Rev Pharmacol Toxicol        ISSN: 0362-1642            Impact factor:   13.820


  38 in total

1.  G-protein-coupled receptor heterodimerization modulates receptor function.

Authors:  B A Jordan; L A Devi
Journal:  Nature       Date:  1999-06-17       Impact factor: 49.962

2.  Recycling and resensitization of delta opioid receptors.

Authors:  N Trapaidze; I Gomes; M Bansinath; L A Devi
Journal:  DNA Cell Biol       Date:  2000-04       Impact factor: 3.311

3.  Molecular modeling study of the differential ligand-receptor interaction at the mu, delta and kappa opioid receptors.

Authors:  M Filizola; M Carteni-Farina; J J Perez
Journal:  J Comput Aided Mol Des       Date:  1999-07       Impact factor: 3.686

4.  Consequences of opioid receptor mutation on actions of univalent and bivalent kappa and delta ligands.

Authors:  Michael A Ansonoff; Philip S Portoghese; John E Pintar
Journal:  Psychopharmacology (Berl)       Date:  2010-03-24       Impact factor: 4.530

Review 5.  Delta opioid receptor analgesia: recent contributions from pharmacology and molecular approaches.

Authors:  Claire Gavériaux-Ruff; Brigitte Lina Kieffer
Journal:  Behav Pharmacol       Date:  2011-09       Impact factor: 2.293

Review 6.  Molecular recognition of opioid receptor ligands.

Authors:  Brian E Kane; Bengt Svensson; David M Ferguson
Journal:  AAPS J       Date:  2006-03-10       Impact factor: 4.009

7.  Spinal or systemic TY005, a peptidic opioid agonist/neurokinin 1 antagonist, attenuates pain with reduced tolerance.

Authors:  T M Largent-Milnes; T Yamamoto; P Nair; J W Moulton; V J Hruby; J Lai; F Porreca; T W Vanderah
Journal:  Br J Pharmacol       Date:  2010-11       Impact factor: 8.739

8.  Activation of delta-opioid receptors reduces excitatory input to putative gustatory cells within the nucleus of the solitary tract.

Authors:  Mingyan Zhu; Young K Cho; Cheng-Shu Li
Journal:  J Neurophysiol       Date:  2008-11-19       Impact factor: 2.714

9.  Delta-opioid receptor antagonists prevent sensitization to the conditioned rewarding effects of morphine.

Authors:  Toni S Shippenberg; Vladimir I Chefer; Alexis C Thompson
Journal:  Biol Psychiatry       Date:  2008-10-31       Impact factor: 13.382

10.  Role of delta-opioid receptor subtypes in anxiety-related behaviors in the elevated plus-maze in rats.

Authors:  Akiyoshi Saitoh; Yuji Yoshikawa; Kenji Onodera; Junzo Kamei
Journal:  Psychopharmacology (Berl)       Date:  2005-10-19       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.